Case Study: AstraZeneca Leverages AI for Innovation

AstraZeneca, a prominent global biopharmaceutical company, is dedicated to researching, developing, manufacturing, and marketing prescription drugs and vaccines across several key therapeutic areas, including oncology, cardiovascular, renal, metabolism, respiratory, and immunology. In 2022, AstraZeneca reported revenues of $42.67 billion and a profit of $4.08 billion, reflecting its significant market presence and robust financial health. By 2023, the company employed approximately 89,900 people across more than 60 countries. With an investment exceeding $250 million in AI research, AstraZeneca is particularly focused on developing innovative cancer treatments and has embedded data and AI throughout its research and development processes.

Key Takeaways

  • AstraZeneca has invested over $250 million in AI research, particularly focusing on cancer treatments.
  • The company has improved data integration by leveraging natural language processing (NLP) to analyze vast data sources, enhancing decision-making and data pipeline efficiency.
  • Adoption of AWS SageMaker has streamlined the machine learning (ML) model lifecycle, improving speed and efficiency.
  • The use of generative AI has enhanced predictive modeling and real-world evidence (RWE) analysis, boosting research and development capabilities.

Approach

AstraZeneca’s approach to integrating AI into its operations is multifaceted. The company utilizes NLP and Databricks to process and analyze extensive datasets from diverse sources, addressing data integration challenges. For machine learning model deployment, AstraZeneca has implemented AWS SageMaker, which automates and streamlines the ML development lifecycle. Additionally, the adoption of generative AI has allowed for more sophisticated data analysis, clinical trial design, and drug development, pushing the boundaries of scientific research and innovation.

Implementation

AstraZeneca tackled its data integration challenges by adopting Databricks, which provided a fully managed platform to simplify cluster management and maintain analytic resources at scale. Key implementation steps included processing and analyzing scientific literature and data sources with NLP, building scalable and performant data pipelines, and constructing a knowledge graph to enhance decision-making and generate novel hypotheses. To streamline ML model deployment, AstraZeneca implemented AWS SageMaker, automating the ML workflow with tools like notebooks, debuggers, and pipelines. This approach facilitated model management, including tracking, registry, and monitoring capabilities, and enabled scalable and repeatable model deployment across various teams.

Results

The integration of AI technologies at AstraZeneca has led to notable improvements in operational efficiency and data science productivity. The automation of routine tasks increased the productivity of data science teams, while the time to generate insights decreased significantly from over six months to less than 2.5 months. The implementation of scalable and repeatable ML models and data processes also enhanced the company’s overall efficiency and capability to derive actionable insights quickly.

Challenges and Barriers

Despite the significant benefits, AstraZeneca encountered several challenges during the AI integration process. These included ensuring seamless integration of diverse data sources, managing a complex infrastructure that required constant upkeep, and creating a cohesive environment for various ML tools. Additionally, the company had to address ethical considerations related to data privacy and the accuracy of AI-generated outputs.

Future Outlook

AstraZeneca remains committed to advancing science and innovation through the strategic use of AI. The company plans to further leverage generative AI to enhance predictive modeling, clinical trial design, and drug development. Integrating advanced data science tools like R will continue to improve data analysis and decision-making. AstraZeneca also aims to address sustainability and ethical considerations in AI development and deployment.

To get the latest AI transformation case studies straight to your inbox, subscribe to AI in Action by AIX — your weekly newsletter dedicated to the exploration of AI adoption in business.

Elevate your understanding of AI transformation. Browse AI adoption case studies searchable by company, industry, use case, and technology.

Sources:
Artificial Intelligence at AstraZeneca
Transforming patient outcomes with generative AI


Let’s talk

Whether you’re looking for expert guidance on AI transformation or want to share your AI knowledge with others, our network is the place for you. Let’s work together to build a brighter future powered by AI.